Supply Chain

McKesson is closing its Delran, N.J. distribution plant at the end of March and laying off the plant's 102 employees, the Philadelphia Inquirer reports.

Valeant Pharmaceuticals took another hit after Goldman Sachs issued a 'sell' rating and an $18 price target Jan. 24, Schaeffer's reports.

The medical device industry had reason to celebrate after Congress suspended the medical device tax for two years through its stopgap spending measure to reopen the government, STAT reports.

Cowen, a notable Wall Street bank, thinks Amazon will leverage Alexa voice assistance technology in the healthcare space, according to a Business Insider report.

The FDA granted IlluminOss Medical de novo clearance for its IlluminOss Bone Stabilization System. 

Healthcare technology company Allscripts signed a definitive agreement to acquire Practice Fusion.

McKesson completed its acquisition of RxCrossroads on Jan. 3.

Allergan announced in a SEC filing it would reduce its workforce by 1,000 employees as part of a cost-reduction effort, CNBC reports.

Valeant Pharmaceuticals and Pershing Square Holdings agreed to pay a combined $290 million to settle claims the two were engaged in insider trading in a failed 2014 bid to takeover Allergan, the Irish Times reports.

OneBlood, a nonprofit blood center, signed a distribution agreement with Medline.